SHISA7
Protein shisa-7
Also known as: SHSA7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NL88
- Gene
- SHISA7
- Ensembl
- ENSG00000187902
- Chromosome
- 19
- Canonical length
- 538 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Cytosol
OverviewNCBI Gene
Predicted to enable GABA receptor binding activity and ionotropic glutamate receptor binding activity. Predicted to be involved in several processes, including gamma-aminobutyric acid receptor clustering; positive regulation of long-term synaptic potentiation; and regulation of signaling receptor activity. Predicted to be located in asymmetric, glutamatergic, excitatory synapse. Predicted to be active in glutamatergic synapse; postsynaptic density; and synaptic membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
538 residues, UniProt reviewed canonical sequence.
>A6NL88|SHISA7
1 MPALLLLVLL ASSAGQARAR PSNATSAEPA GPLPALLAHL RRLTGALTGG GGAASPGANG
61 TRTGPAGGAG AAARAPPPAE LCHGYYDVMG QYDATFNCST GSYRFCCGTC HYRFCCEHRH
121 MRLAQASCSN YDTPRWATTP PPLAGGAGGA GGAGGGPGPG QAGWLEGGRT GGAGGRGGEG
181 PGGSTAYVVC GVISFALAVG VGAKVAFSKA SRAPRAHRDI NVPRALVDIL RHQAGPGTRP
241 DRARSSSLTP GIGGPDSMPP RTPKNLYNTV KTPNLDWRAL PPPSPSLHYS TLSCSRSFHN
301 LSHLPPSYEA AVKSELNRYS SLKRLAEKDL DEAYLKRRPL ELPRGTLPLH ALRRPGTGGG
361 YRMEAWGGPE ELGLAPAPNP RRVMSQEHLL GDGGRSRYEF TLPRARLVSQ EHLLLSSPEA
421 LRQSREHLLS PPRSPALPPD PTARASLAAS HSNLLLGPGG PPTPLRGLPP PSSLHAHHHH
481 ALHGSPQPAW MSDAGGGGGT LARRPPFQRQ GTLEQLQFIP GHHLPQHLRT ASKNEVTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SHISA7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 25 nTPM
- hippocampal formation: 19 nTPM
- cerebral cortex: 19 nTPM
- amygdala: 15 nTPM
- hypothalamus: 13 nTPM
- spinal cord: 6.6 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 58 nCPM
- brain inhibitory neurons: 38 nCPM
- oligodendrocytes: 25 nCPM
- brain excitatory neurons: 25 nCPM
- other brain neurons: 21 nCPM
- retinal amacrine cells: 12 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 66 nTPM
- amygdala: 54 nTPM
- cerebral cortex: 54 nTPM
- basal ganglia: 53 nTPM
- white matter: 36 nTPM
- hypothalamus: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0.85
- gnomAD missense Z
- 1.74
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- gamma-aminobutyric acid receptor clustering
- gamma-aminobutyric acid signaling pathway
- memory
- positive regulation of long-term synaptic potentiation
- regulation of GABA-A receptor activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SHISA7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SHISA7 as an antibody target. Whether an autoantibody or antibody against SHISA7 could matter depends on whether native SHISA7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SHISA7 is annotated at the cell surface, where native SHISA7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SHISA7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...